This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Pharmaceutical Contract Packaging Market

Market Insights on Pharmaceutical Contract Packaging covering sales outlook, demand forecast & up-to-date key trends

Pharmaceutical contract packaging Market by Type, Form, Application & Region - Forecast 2022 – 2032

Pharmaceutical Contract Packaging Market Outlook (2022-2032)

[340 Pages Report] The global pharmaceutical contract packaging market is forecasted to be valued at US$ 11,586 Mn by 2032, up from US$ 5,674 Mn in 2022, projecting a CAGR of 7.4% during the forecast period.

Report Attribute

Details

Pharmaceutical Contract Packaging Market Value (2022)

US$ 5,674 Mn

Pharmaceutical Contract Packaging Market Anticipated Value (2032)

US$ 11,586 Mn

Pharmaceutical Contract Packaging Projected Growth Rate (2032)

7.4%

Rising prevalence of diseases such as diabetes and asthma due to the growing aging population is anticipated to fuel the pharmaceutical contract packaging market growth.

Establishing mutually beneficial relationships with Contract Packaging Organizations (CPOs) and Contract Development & Manufacturing (CDMOs) to avoid lack of resources and budgets is the pharmaceutical contract packaging market size. Furthermore, the adoption of pharmaceutical contract packaging is anticipated to rise owing to implementation of serialization that mandates the barcodes and transfer of large volumes of data in the supply of medicines.

The rising prevalence of atmosphere sensitive pharmaceutical drugs surged the demand for silica-based packaging material are some of the latest pharmaceutical contract packaging market trends. Moreover, witnessing a proliferation of the geriatric population in developed regions highly dependent on pharmaceutical drugs for maintaining good health is projected to boost the sales of pharmaceutical contract packaging.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Key Pharmaceutical Contract Packaging Market Dynamics?

The implementation of advanced manufacturing techniques and technological advancements, higher spending in public healthcare systems owing to population increase and health awareness are some of the major factors driving pharmaceutical contract packaging market growth.

Government execution of new regulations to control the spreading of contagious diseases, new treatments such as gene and cell therapies and growing demand for bio-products are some of the factors driving the adoption of pharmaceutical contract packaging.

Generic pharmaceuticals of lower cost increasing in popularity in developing economies as well as generic drugs requiring efficient packaging and protection during storage and shipping is projected to boost the demand for pharmaceutical contract packaging. The capability of vendors to take undertake several packaging projects, including sorting issues arising complex packaging requirements surges the adoption of pharmaceutical contract packaging.

Investment in R&D activities to enhance the quality of their services and meet consumer demands is anticipated to boost the pharmaceutical contract packaging market growth.

What are the Drawbacks of Pharmaceutical Contract Packaging?

Increasing risks associated with the poor quality of the product as well as fluctuating prices of raw materials used for manufacturing pharmaceutical packaging products are some of the factors anticipated to hamper the market growth. The availability of counterfeit medicines containing false or inactive ingredients across the globe, significantly hinders the global pharmaceutical contract packaging market growth.

Restricted information sharing with contract packages in fear of vulnerability as well as lack of expertise, in-house packaging capabilities and budget constraints further obstructs the pharmaceutical contract packaging market share.

Ismail Sutaria
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What is the Scope of the Pharmaceutical Contract Packaging Market?

The pharmaceutical contract packaging market share is projected to rise owing to the increasing utilization of smart packaging solutions such as smart labels. Furthermore, R&D activities to develop advanced plastics and increase development of patient-specific implants and 3D printed devices drives the sales of pharmaceutical contract packaging.

Increasing demand for eco-friendly and reusable packaging in regards to environment sustainability as well as rise in the e-commerce industry allowing vendors to expand their business to a wider audience. A scale-oriented acquisition strategy represented owing to the merger between cloud packaging companies and their clientele, promotes the pharmaceutical contract packaging market growth.

Stakeholders re-shuffling their production activities to adapt to the demands of the healthcare infrastructures increases the global pharmaceutical contract packaging market share. Government agencies implementing stricter norms on packaging, as well as increasing consumer interest for innovative packaging fuels the demand for pharmaceutical contract packaging.

Regional Insights on the Pharmaceutical Contract Packaging Market

How is the Performance of the North America Pharmaceutical Contract Packaging Market?

North America accounts for the leading pharmaceutical contract packaging market share of 33%. Quality services offered by the CPOs and CDMOs based in the U.S. propels the demand for pharmaceutical contract packaging in the region. The demand for biological therapies, increase in strict protocols, and rise in the geriatric population broadens the global pharmaceutical contract packaging market size.

What is the Growth Outlook for the Europe Pharmaceutical Contract Packaging Market?

Europe holds a 28% revenue in the pharmaceutical contract packaging market share, and is the second most dominating market. Large presence of major manufacturers operating the pharmaceutical industry creates lucrative opportunities and increases the adoption of pharmaceutical contract packaging. Increasing use of pharmaceutical products such as plastic bottles and containers, vials & ampoules, and pre-fillable syringes are anticipated to boost the demand for pharmaceutical contract packaging in this region.

How is the Asia-Pacific Pharmaceutical Contract Packaging Market Outlook?

The Asia Pacific is anticipated to grow at highest CAGR in the pharmaceutical contract packaging market. Increasing demand for biological therapies and rigid protocols associated with packaging processes as well as the presence of several pharmaceutical contact packaging service providers in the region boost the overall market size.

The sales of pharmaceutical contract packaging is anticipated to rise owing to the rapid outsourcing of pharmaceutical manufacturing to emerging countries, such as India.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

How is the Start-up Ecosystem in the Pharmaceutical Contract Packaging Market?

To protect pharmaceutical products better than conventional materials, startups in the pharmaceutical contract packaging strive to develop enhanced packaging solutions.

Exposure to heat, light, air, and moisture can negatively affect the efficacy of pharmaceutical products, as they are highly reactive.  Medical products have to be kept at or below room temperature and isolated using containers. However, a significant amount of medicine wastage can be the result of low-quality packaging and poor handling as well.

Hence, some start-up companies such as Veneti, Unipharm Healthy Manufacturing, V-Shapes, Blistr, Calyx Containers, etc. are coming up with various strategies to improve the pharmaceutical contract packaging market share, like medical cannabis containers, biodegradable pharma packaging, single-portion packets, contract pharmaceuticals packaging with labelling and distribution, etc.

This is changing the landscape of pharmaceutical contact packaging and generating newer and more innovative ideas to tackle every challenge.

Competition Landscape of the Pharmaceutical Contract Packaging Market

Improving pharmaceutical packaging so that it can withstand adverse environmental conditions is a major priority for key players in the pharmaceutical contract packaging market share.

Some of the key players of the pharmaceutical contract packaging market are Catalent Pharma Solutions, Patheon, Baxter BioPharma Solutions, AbbVie Contract Manufacturing, Pfizer CentreSource, Daito Pharmaceutical, Nipro Corporation, Becton Dickinson & Company, AptarGroup Inc., Drug Plastics Group, Gerresheimer AG, Schott AG, Owens Illinois Inc., WestRock Company SGD S.A., International Paper Company, COMAR LLC, CCL Industries Inc., Vetter Pharma International, Adelphi Healthcare Packaging, Sharp Corporation, Amcor Limited, Berry Plastics Corporation, MeadWestvaco Corporation, Becton Dickinson and Company, Owens-Illinois Inc., West Pharmaceuticals Services Inc., Schott Pharmaceuticals Services Inc., RPC Group Plc, Graphic Packaging International Inc., etc.

Some of the recent developments in the pharmaceutical contract packaging are:            

  • In January 2021, Nelipak Laboratory Services completed the collaboration of a new climatic conditioning compartment to meet the amplified demand for conditioning.
  • In December 2020, ProAmpac acquired Rosenbloom Groupe Inc., Hymopack Ltd., and Dyne-A-Pak, based in Canada that manufacture packaging products, to enhance the manufacturing capabilities of the company.
  • In May 2021, Sharp - a clinical services company owned by UDG Healthcare plc, purchased new land as part of a US$ 17 Mn investment in its Conshohocken, PA, to add future capacity for cGMP packaging services.
  • In June 2020, PCI Pharma announced a partnership agreement with Experic, to explore clinical and commercial manufacturing, packaging, and supply chain services driving collective growth for both parties.

Table:

Report Attribute 

Details

Growth Rate

CAGR of 7.4% from 2022 to 2032

Base year for estimation 

2021

Historical data 

2016 - 2021

Forecast period 

2022 - 2032

Quantitative units 

Revenue in USD million and CAGR from 2022 to 2032

Report coverage 

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,

Segments covered 

Type, Form, Application, and Region.

Regional scope 

North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand 

Country scope 

U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa

Key companies profiled 

Catalent Pharma Solutions, Patheon, Baxter BioPharma Solutions, AbbVie Contract Manufacturing, Pfizer CentreSource, Daito Pharmaceutical, Nipro Corporation, Becton Dickinson & Company, AptarGroup Inc., Drug Plastics Group, Gerresheimer AG, Schott AG, Owens Illinois Inc., WestRock Company SGD S.A., International Paper Company, COMAR LLC, CCL Industries Inc., Vetter Pharma International, Adelphi Healthcare Packaging, Sharp Corporation, Amcor Limited, Berry Plastics Corporation, MeadWestvaco Corporation, Becton Dickinson and Company, Owens-Illinois Inc., West Pharmaceuticals Services Inc., Schott Pharmaceuticals Services Inc., RPC Group Plc, Graphic Packaging International Inc., etc.

Customization scope

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options 

Avail customized purchase options to meet your exact research needs.

Key Segments

By Type:

  • Flexible Packaging
  • Plastic/Glass Containers
  • Caps/Closures

By Form:

  • Oral
  • Injectable

By Application:

  • Autacoids & Related Drugs
  • Contraceptives
  • Hormone Replacement
  • Cardiovascular Medicines
  • Cancer Therapies

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

The pharmaceutical contract packaging market is predicted to garner a CAGR of 7.4% through 2032.

The pharmaceutical contract packaging market is expected to surpass US$ 11,586 Mn by 2032.

North America dominates the pharmaceutical contract packaging market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2022-2032

        5.3.1. Flexible Packaging

        5.3.2. Plastic Containers

        5.3.3. Glass Containers

        5.3.4. Caps/Closures

    5.4. Y-o-Y Growth Trend Analysis By Product, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Product, 2022-2032

6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Drug Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Drug Type, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Drug Type, 2022-2032

        6.3.1. Autacoids & Related Drugs

        6.3.2. Contraceptives

        6.3.3. Hormone Replacement

        6.3.4. Cardiovascular Medicines

        6.3.5. Cancer Therapies

    6.4. Y-o-Y Growth Trend Analysis By Drug Type, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Drug Type, 2022-2032

7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Drug Form

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By Drug Form, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Drug Form, 2022-2032

        7.3.1. Oral

        7.3.2. Injectable

    7.4. Y-o-Y Growth Trend Analysis By Drug Form, 2017-2021

    7.5. Absolute $ Opportunity Analysis By Drug Form, 2022-2032

8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Product

        9.2.3. By Drug Type

        9.2.4. By Drug Form

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By Drug Type

        9.3.4. By Drug Form

    9.4. Key Takeaways

10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product

        10.2.3. By Drug Type

        10.2.4. By Drug Form

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By Drug Type

        10.3.4. By Drug Form

    10.4. Key Takeaways

11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. U.K.

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Product

        11.2.3. By Drug Type

        11.2.4. By Drug Form

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Drug Type

        11.3.4. By Drug Form

    11.4. Key Takeaways

12. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

            12.2.1.4. India

            12.2.1.5. Malaysia

            12.2.1.6. Singapore

            12.2.1.7. Australia

            12.2.1.8. New Zealand

            12.2.1.9. Rest of APAC

        12.2.2. By Product

        12.2.3. By Drug Type

        12.2.4. By Drug Form

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Drug Type

        12.3.4. By Drug Form

    12.4. Key Takeaways

13. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. GCC Countries

            13.2.1.2. South Africa

            13.2.1.3. Israel

            13.2.1.4. Rest of MEA

        13.2.2. By Product

        13.2.3. By Drug Type

        13.2.4. By Drug Form

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Drug Type

        13.3.4. By Drug Form

    13.4. Key Takeaways

14. Key Countries Market Analysis

    14.1. U.S.

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2021

            14.1.2.1. By Product

            14.1.2.2. By Drug Type

            14.1.2.3. By Drug Form

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2021

            14.2.2.1. By Product

            14.2.2.2. By Drug Type

            14.2.2.3. By Drug Form

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2021

            14.3.2.1. By Product

            14.3.2.2. By Drug Type

            14.3.2.3. By Drug Form

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2021

            14.4.2.1. By Product

            14.4.2.2. By Drug Type

            14.4.2.3. By Drug Form

    14.5. Germany

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2021

            14.5.2.1. By Product

            14.5.2.2. By Drug Type

            14.5.2.3. By Drug Form

    14.6. U.K.

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2021

            14.6.2.1. By Product

            14.6.2.2. By Drug Type

            14.6.2.3. By Drug Form

    14.7. France

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2021

            14.7.2.1. By Product

            14.7.2.2. By Drug Type

            14.7.2.3. By Drug Form

    14.8. Spain

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2021

            14.8.2.1. By Product

            14.8.2.2. By Drug Type

            14.8.2.3. By Drug Form

    14.9. Italy

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2021

            14.9.2.1. By Product

            14.9.2.2. By Drug Type

            14.9.2.3. By Drug Form

    14.10. China

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2021

            14.10.2.1. By Product

            14.10.2.2. By Drug Type

            14.10.2.3. By Drug Form

    14.11. Japan

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2021

            14.11.2.1. By Product

            14.11.2.2. By Drug Type

            14.11.2.3. By Drug Form

    14.12. South Korea

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2021

            14.12.2.1. By Product

            14.12.2.2. By Drug Type

            14.12.2.3. By Drug Form

    14.13. Malaysia

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2021

            14.13.2.1. By Product

            14.13.2.2. By Drug Type

            14.13.2.3. By Drug Form

    14.14. Singapore

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2021

            14.14.2.1. By Product

            14.14.2.2. By Drug Type

            14.14.2.3. By Drug Form

    14.15. Australia

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2021

            14.15.2.1. By Product

            14.15.2.2. By Drug Type

            14.15.2.3. By Drug Form

    14.16. New Zealand

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2021

            14.16.2.1. By Product

            14.16.2.2. By Drug Type

            14.16.2.3. By Drug Form

    14.17. GCC Countries

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2021

            14.17.2.1. By Product

            14.17.2.2. By Drug Type

            14.17.2.3. By Drug Form

    14.18. South Africa

        14.18.1. Pricing Analysis

        14.18.2. Market Share Analysis, 2021

            14.18.2.1. By Product

            14.18.2.2. By Drug Type

            14.18.2.3. By Drug Form

    14.19. Israel

        14.19.1. Pricing Analysis

        14.19.2. Market Share Analysis, 2021

            14.19.2.1. By Product

            14.19.2.2. By Drug Type

            14.19.2.3. By Drug Form

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Product

        15.3.3. By Drug Type

        15.3.4. By Drug Form

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. Catalent Pharma Solutions

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segments

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

        16.1.2. Patheon

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segments

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

        16.1.3. Baxter BioPharma Solutions

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segments

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

        16.1.4. AbbVie Contract Manufacturing

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segments

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

        16.1.5. Pfizer CentreSource

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segments

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

        16.1.6. Daito Pharmaceutical

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segments

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

        16.1.7. Nipro Corporation

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segments

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

        16.1.8. BALL CORPORATION

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segments

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

        16.1.9. Amcor plc

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segments

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

        16.1.10. WestRock Company

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segments

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Market Value (US$ Mn) Forecast by Product, 2017-2032

Table 3: Global Market Value (US$ Mn) Forecast by Drug Type, 2017-2032

Table 4: Global Market Value (US$ Mn) Forecast by Drug Form, 2017-2032

Table 5: North America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 6: North America Market Value (US$ Mn) Forecast by Product, 2017-2032

Table 7: North America Market Value (US$ Mn) Forecast by Drug Type, 2017-2032

Table 8: North America Market Value (US$ Mn) Forecast by Drug Form, 2017-2032

Table 9: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: Latin America Market Value (US$ Mn) Forecast by Product, 2017-2032

Table 11: Latin America Market Value (US$ Mn) Forecast by Drug Type, 2017-2032

Table 12: Latin America Market Value (US$ Mn) Forecast by Drug Form, 2017-2032

Table 13: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Europe Market Value (US$ Mn) Forecast by Product, 2017-2032

Table 15: Europe Market Value (US$ Mn) Forecast by Drug Type, 2017-2032

Table 16: Europe Market Value (US$ Mn) Forecast by Drug Form, 2017-2032

Table 17: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 18: Asia Pacific Market Value (US$ Mn) Forecast by Product, 2017-2032

Table 19: Asia Pacific Market Value (US$ Mn) Forecast by Drug Type, 2017-2032

Table 20: Asia Pacific Market Value (US$ Mn) Forecast by Drug Form, 2017-2032

Table 21: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 22: MEA Market Value (US$ Mn) Forecast by Product, 2017-2032

Table 23: MEA Market Value (US$ Mn) Forecast by Drug Type, 2017-2032

Table 24: MEA Market Value (US$ Mn) Forecast by Drug Form, 2017-2032

Ismail Sutaria
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Mn) by Product, 2022-2032

Figure 2: Global Market Value (US$ Mn) by Drug Type, 2022-2032

Figure 3: Global Market Value (US$ Mn) by Drug Form, 2022-2032

Figure 4: Global Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global Market Value (US$ Mn) Analysis by Product, 2017-2032

Figure 9: Global Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 10: Global Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 11: Global Market Value (US$ Mn) Analysis by Drug Type, 2017-2032

Figure 12: Global Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032

Figure 13: Global Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032

Figure 14: Global Market Value (US$ Mn) Analysis by Drug Form, 2017-2032

Figure 15: Global Market Value Share (%) and BPS Analysis by Drug Form, 2022-2032

Figure 16: Global Market Y-o-Y Growth (%) Projections by Drug Form, 2022-2032

Figure 17: Global Market Attractiveness by Product, 2022-2032

Figure 18: Global Market Attractiveness by Drug Type, 2022-2032

Figure 19: Global Market Attractiveness by Drug Form, 2022-2032

Figure 20: Global Market Attractiveness by Region, 2022-2032

Figure 21: North America Market Value (US$ Mn) by Product, 2022-2032

Figure 22: North America Market Value (US$ Mn) by Drug Type, 2022-2032

Figure 23: North America Market Value (US$ Mn) by Drug Form, 2022-2032

Figure 24: North America Market Value (US$ Mn) by Country, 2022-2032

Figure 25: North America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America Market Value (US$ Mn) Analysis by Product, 2017-2032

Figure 29: North America Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 30: North America Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 31: North America Market Value (US$ Mn) Analysis by Drug Type, 2017-2032

Figure 32: North America Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032

Figure 33: North America Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032

Figure 34: North America Market Value (US$ Mn) Analysis by Drug Form, 2017-2032

Figure 35: North America Market Value Share (%) and BPS Analysis by Drug Form, 2022-2032

Figure 36: North America Market Y-o-Y Growth (%) Projections by Drug Form, 2022-2032

Figure 37: North America Market Attractiveness by Product, 2022-2032

Figure 38: North America Market Attractiveness by Drug Type, 2022-2032

Figure 39: North America Market Attractiveness by Drug Form, 2022-2032

Figure 40: North America Market Attractiveness by Country, 2022-2032

Figure 41: Latin America Market Value (US$ Mn) by Product, 2022-2032

Figure 42: Latin America Market Value (US$ Mn) by Drug Type, 2022-2032

Figure 43: Latin America Market Value (US$ Mn) by Drug Form, 2022-2032

Figure 44: Latin America Market Value (US$ Mn) by Country, 2022-2032

Figure 45: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America Market Value (US$ Mn) Analysis by Product, 2017-2032

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 51: Latin America Market Value (US$ Mn) Analysis by Drug Type, 2017-2032

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032

Figure 54: Latin America Market Value (US$ Mn) Analysis by Drug Form, 2017-2032

Figure 55: Latin America Market Value Share (%) and BPS Analysis by Drug Form, 2022-2032

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Drug Form, 2022-2032

Figure 57: Latin America Market Attractiveness by Product, 2022-2032

Figure 58: Latin America Market Attractiveness by Drug Type, 2022-2032

Figure 59: Latin America Market Attractiveness by Drug Form, 2022-2032

Figure 60: Latin America Market Attractiveness by Country, 2022-2032

Figure 61: Europe Market Value (US$ Mn) by Product, 2022-2032

Figure 62: Europe Market Value (US$ Mn) by Drug Type, 2022-2032

Figure 63: Europe Market Value (US$ Mn) by Drug Form, 2022-2032

Figure 64: Europe Market Value (US$ Mn) by Country, 2022-2032

Figure 65: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe Market Value (US$ Mn) Analysis by Product, 2017-2032

Figure 69: Europe Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 71: Europe Market Value (US$ Mn) Analysis by Drug Type, 2017-2032

Figure 72: Europe Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032

Figure 74: Europe Market Value (US$ Mn) Analysis by Drug Form, 2017-2032

Figure 75: Europe Market Value Share (%) and BPS Analysis by Drug Form, 2022-2032

Figure 76: Europe Market Y-o-Y Growth (%) Projections by Drug Form, 2022-2032

Figure 77: Europe Market Attractiveness by Product, 2022-2032

Figure 78: Europe Market Attractiveness by Drug Type, 2022-2032

Figure 79: Europe Market Attractiveness by Drug Form, 2022-2032

Figure 80: Europe Market Attractiveness by Country, 2022-2032

Figure 81: Asia Pacific Market Value (US$ Mn) by Product, 2022-2032

Figure 82: Asia Pacific Market Value (US$ Mn) by Drug Type, 2022-2032

Figure 83: Asia Pacific Market Value (US$ Mn) by Drug Form, 2022-2032

Figure 84: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032

Figure 85: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: Asia Pacific Market Value (US$ Mn) Analysis by Product, 2017-2032

Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 91: Asia Pacific Market Value (US$ Mn) Analysis by Drug Type, 2017-2032

Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032

Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032

Figure 94: Asia Pacific Market Value (US$ Mn) Analysis by Drug Form, 2017-2032

Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by Drug Form, 2022-2032

Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by Drug Form, 2022-2032

Figure 97: Asia Pacific Market Attractiveness by Product, 2022-2032

Figure 98: Asia Pacific Market Attractiveness by Drug Type, 2022-2032

Figure 99: Asia Pacific Market Attractiveness by Drug Form, 2022-2032

Figure 100: Asia Pacific Market Attractiveness by Country, 2022-2032

Figure 101: MEA Market Value (US$ Mn) by Product, 2022-2032

Figure 102: MEA Market Value (US$ Mn) by Drug Type, 2022-2032

Figure 103: MEA Market Value (US$ Mn) by Drug Form, 2022-2032

Figure 104: MEA Market Value (US$ Mn) by Country, 2022-2032

Figure 105: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 106: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: MEA Market Value (US$ Mn) Analysis by Product, 2017-2032

Figure 109: MEA Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 110: MEA Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 111: MEA Market Value (US$ Mn) Analysis by Drug Type, 2017-2032

Figure 112: MEA Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032

Figure 113: MEA Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032

Figure 114: MEA Market Value (US$ Mn) Analysis by Drug Form, 2017-2032

Figure 115: MEA Market Value Share (%) and BPS Analysis by Drug Form, 2022-2032

Figure 116: MEA Market Y-o-Y Growth (%) Projections by Drug Form, 2022-2032

Figure 117: MEA Market Attractiveness by Product, 2022-2032

Figure 118: MEA Market Attractiveness by Drug Type, 2022-2032

Figure 119: MEA Market Attractiveness by Drug Form, 2022-2032

Figure 120: MEA Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Packaging Insights

View Reports

Recommendations

Packaging

Pharmaceutical Ampoules Market

Published : July 2021

Packaging

Pharmaceutical Packaging Market

Published : May 2021

Packaging

Pharmaceutical Vials Market

Published : July 2021

Packaging

Pharmaceuticals Pouch Market

Published : October 2017

Google translate

Pharmaceutical Contract Packaging Market